Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.77%
1,097.81
-8.55
-0.77%
1,106.361,105.681,109.291,096.52
SIXC
Communications
SIXC
Communications
SIXC
+0.29%
612.03
+1.74
+0.29%
610.29610.29616.60610.29
SIXE
Energy
SIXE
Energy
SIXE
+0.76%
1,220.43
+9.21
+0.76%
1,211.221,211.011,222.361,208.50
SIXI
Industrials
SIXI
Industrials
SIXI
+0.50%
1,759.52
+8.81
+0.50%
1,750.711,753.101,762.131,743.30
SIXM
Financials
SIXM
Financials
SIXM
+0.54%
631.54
+3.37
+0.54%
628.17629.38634.09629.38
SIXR
Staples
SIXR
Staples
SIXR
+0.30%
857.16
+2.59
+0.30%
854.57855.71860.09855.45
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.67%
215.41
-1.46
-0.67%
216.87216.87217.79215.29
SIXT
Technology
SIXT
Technology
SIXT
+1.47%
3,614.15
+52.21
+1.47%
3,561.943,571.443,628.583,562.15
SIXU
Utilities
SIXU
Utilities
SIXU
+0.55%
908.30
+4.99
+0.55%
903.31903.26908.38901.18
SIXV
Health care
SIXV
Health care
SIXV
-0.08%
1,480.40
-1.14
-0.08%
1,481.541,482.481,488.461,474.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.07%
2,398.37
-1.58
-0.07%
2,399.952,404.452,418.812,396.04
CATX:NYSEAMERICAN
Perspective Therapeutics Inc
$3.86
+1.05%
(+0.040) 1D
$3.95
+2.33% (+0.090)
After hours
Closed: May 14, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CATX...
Open
$3.85
High
$3.95
Low
$3.71
Mkt. cap
440.22M
Avg. vol.
1.34M
Volume
840.80K
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.40
Beta
1.75
Shares outstanding
114.05M
No. of employees
163
News stories
From sources across the web
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu. The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
290.00K
209.00K
43.00K
76.00K
Cost of goods sold
16.62M
20.34M
32.92M
21.37M
Cost of revenue
16.62M
20.34M
32.92M
21.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.71M
7.73M
6.95M
6.98M
Operating expense
7.71M
7.73M
6.95M
6.98M
Total operating expenses
24.33M
28.07M
39.88M
28.36M
Operating income
-24.04M
-27.86M
-39.83M
-28.28M
Other non operating income
-
-
-
-
EBT including unusual items
-22.00M
-25.97M
-38.28M
-26.19M
EBT excluding unusual items
-22.00M
-25.97M
-38.28M
-26.19M
Income tax expense
-
-
-793.00K
-
Effective tax rate
-
-
2.07%
-
Other operating expenses
-
-
-
-
Net income
-21.48M
-25.97M
-37.49M
-26.19M
Net profit margin
-7,408.62%
-12,425.36%
-87,186.05%
-34,459.21%
Earnings per share
-0.30
-0.35
-0.51
-0.25
Interest and investment income
2.16M
1.96M
1.61M
2.20M
Interest expense
-119.00K
-65.00K
-64.00K
-105.00K
Net interest expenses
2.04M
1.89M
1.55M
2.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
-23.31M
-27.09M
-38.83M
-27.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more